Mikhail Kogan, MD, ABOIM, will present new evidence on how CBD and other cannabinoids may fit into newly emerging, multi-modal approaches for the most common neuro-cognitive disorders. This one hour learning opportunity will include a review of Case Studies and successful treatment approaches used in his practice.
Participation in this educational webinar is $50 and provides 1CME/CEU credit*. Kindly call 877-560-6696 with your payment method after completing the registration form below.
At the conclusion of this presentation and Q&A session, participants should be equipped to:
- Understand principles of the endocannabinoid system and how they apply to the central nervous system
- Recognize the known links between disruptions in the endocannabinoid system and neurodegenerative conditions such as Parkinson's and Alzheimer's disease
- Integrate therapeutic methods based on best existing evidence for use of exogenous cannabinoids for patients with Alzheimer's, Parkinson's and Multiple Sclerosis.
Dr. Kogan currently serves as medical director of the GW Center for Integrative Medicine and associate director of the Geriatric and Integrative Medicine Fellowships at the George Washington University School of Medicine.